Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ImmunoPrecise Antibodies Ltd.

https://www.immunoprecise.com/

Latest From ImmunoPrecise Antibodies Ltd.

Pierre Fabre Fights Off Rivals For Rights To Atara's Allogeneic T-Cell Therapy

After paying $45m upfront, the French firm has beaten off considerable competition to seal the European, Middle East and African rights to tabelecleucel which will be filed next month for Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

Cancer Deals

Deal Watch: Lilly Finds New Partners For Genetic Disorders, Protein Degradation

Pharma’s latest partnerships focus on Duchenne muscular dystrophy with Precision Biosciences, protein degradation with Seed. Bristol and Schrodinger team in computational drug discovery.

Deals Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Contract Manufacturing Organization
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Talem Therapeutics
    • U-Protein Express BV
    • IPA
    • ModiQuest Research
UsernamePublicRestriction

Register